Salicylic Acid

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the removal of common warts, which are characterized by their rough, 'cauliflower-like' appearance.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The affected area should be washed thoroughly, and if necessary, the wart may be soaked in warm water for approximately 5 minutes to facilitate treatment. After soaking, the area must be dried completely.

If the medicated patch requires adjustment, it may be cut to fit the size of the wart. The patch should then be applied adhesive side down directly onto the wart. To ensure proper coverage, the patch should be concealed with a pad.

This procedure should be repeated every 48 hours as needed, continuing until the wart is removed, with a maximum treatment duration of up to 12 weeks.

Contraindications

Use of this product is contraindicated in patients with diabetes or poor blood circulation, unless prescribed and monitored by a qualified healthcare professional, such as a doctor or podiatrist.

Warnings and Precautions

This product is intended for external use only. It is imperative that healthcare professionals advise patients against using this product if they are diabetic or have poor blood circulation, unless under the guidance and supervision of a qualified healthcare provider, such as a doctor or podiatrist.

The product should not be applied to irritated, infected, or reddened skin. Additionally, it is contraindicated for use on moles, birthmarks, and warts that have hair growing from them. Special caution should be exercised to avoid application on genital warts and warts located on the face, as well as on mucous membranes.

In the event of accidental ingestion, immediate medical assistance should be sought, or the local Poison Control Center should be contacted without delay. Should discomfort persist following use, it is recommended that the patient consult with their doctor or podiatrist for further evaluation and management.

Side Effects

Patients using this product should be aware that it is for external use only. It is contraindicated for individuals who are diabetic or have poor blood circulation, unless under the advice and supervision of a healthcare professional, such as a doctor or podiatrist.

The product should not be applied to irritated, infected, or reddened skin, nor should it be used on moles, birthmarks, or warts with hair growing from them. Additionally, it is not recommended for use on genital warts, warts on the face, or mucous membranes.

In the event of accidental ingestion, it is crucial to keep the product out of reach of children. If swallowed, patients should seek medical assistance or contact a Poison Control Center immediately.

Patients are advised to discontinue use and consult a doctor or podiatrist if discomfort persists.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Salicylic Acid (wart removers). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

Pregnant patients should be advised against the use of this product if they have diabetes or poor blood circulation, unless under the guidance and supervision of a healthcare professional. The safety of this product during pregnancy has not been established, and its use on irritated, infected, or reddened skin, as well as on moles, birthmarks, warts with hair, genital warts, and warts on the face or mucous membranes, is contraindicated.

Healthcare providers should counsel women of childbearing potential to keep this product out of reach of children. In the event of accidental ingestion, immediate medical assistance or contact with a Poison Control Center is recommended. If discomfort persists after application, patients should be instructed to discontinue use and consult a physician.

Lactation

There is no specific information available regarding the use of this product in lactating mothers. Additionally, there is no data concerning the potential for excretion of the product in breast milk or its effects on breastfed infants. Healthcare professionals should consider the lack of information when advising lactating mothers on the use of this product.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the drug insert text regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to individuals with reduced kidney function, as the lack of data necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in these patients, although specific recommendations are not provided.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the event of an overdosage, immediate medical assistance is crucial. If the substance is ingested, healthcare professionals should advise patients or caregivers to seek medical help or contact a Poison Control Center without delay.

Prompt intervention is essential to mitigate potential adverse effects associated with overdosage. Symptoms may vary depending on the specific substance involved; therefore, a thorough assessment by a medical professional is recommended to determine the appropriate course of action.

Management procedures may include supportive care and symptomatic treatment, tailored to the individual patient's needs. It is imperative that healthcare providers remain vigilant and prepared to address any complications that may arise from an overdosage scenario.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center if the product is swallowed. It is crucial to inform patients that this product should not be used by individuals who are diabetic or have poor blood circulation unless specifically directed and supervised by a healthcare professional, such as a doctor or podiatrist.

Additionally, patients should be counseled to consult their doctor or podiatrist if they experience persistent discomfort while using the product. This guidance is essential to ensure patient safety and appropriate management of their health conditions.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product within a temperature range of 59°F to 86°F (15°C to 30°C) to maintain its integrity and efficacy. Proper storage conditions must be adhered to, ensuring that the product is kept in a suitable container that protects it from environmental factors. Special handling requirements should be followed to prevent any compromise to the product's quality.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Salicylic Acid, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)